NDC 58160-855-01 - Arepanrix
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58160-855
- Requested NDC
- 58160-855-01
- Package NDCs from labels
- 58160-855-01, 58160-855-19
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Effective date
- 2026-04-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Arepanrix - GlaxoSmithKline Biologicals SA | GlaxoSmithKline Biologicals SA | 2026-04-28 | VACCINE LABEL |
| AS03 - GlaxoSmithKline Biologicals SA | GlaxoSmithKline Biologicals SA | 2025-12-31 | VACCINE LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58160-855-19 | 2024-02-10 | C162847 | 48780-1 | 1030e365-6622-111a-e063-dadaa90a10e2 | f136b41b-56f3-43a9-9d6a-61b2afca5b4a |
| 58160-855-19 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6622-111a-e063-dadaa90a10e2 | f136b41b-56f3-43a9-9d6a-61b2afca5b4a |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58160-855-01 | AS03 | 2.5 mL in 1 VIAL | INJECTION, SOLUTION | 2.5 | 3 | |
| 58160-855-19 | AS03 | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Virility Liquescence | AVENA SATIVA, DAMIANA, BERBERIS VULGARIS, EPIMEDIUM GRANDIFLORUM, GLYCERINUM, SABAL SERRULATA, IODIUM, LECITHIN, FERRUM MURIATICUM, NATRUM MURIATICUM, AGNUS CASTUS, BUFO RANA, CINCHONA OFFICINALIS, HUMAN GROWTH HORMONE (HGH), ORCHITINUM (BOVINE), PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM VALERIANICUM, OOPHORINUM (SUIS), SEPIA | Nutritional Specialties, Inc. | 81cc3e2b-f95e-4ba4-a15f-c07b4def0e2f | 2023-03-29 | Warnings | 451W47IQ8X |
| Spleen Thymus Liquescence | CINCHONA OFFICINALIS, QUERCUS GLANDIUM SPIRITUS, CEANOTHUS AMERICANUS, SPLEEN (BOVINE), THYMUS (BOVINE), CHININUM ARSENICOSUM, NATRUM MURIATICUM, HELIANTHUS ANNUUS | Nutritional Specialties, Inc. | bc1cc31e-0e8a-49a2-9654-f00eaa72fc04 | 2023-03-24 | Warnings | 451W47IQ8X |
| Myco Immuno Nosode | DU HUO (ANGELICA PUBESCENS), ANGELICA ARCHANGELICA, KALI MURIATICUM, RADIX SILERIS (SAPOSHNIKOVIA DIVARICATA), YUCCA FILAMENTOSA, ACHYRANTHES BIDENTATA, ANGELICA SINENSIS, LIGUSTICUM PORTERI, PANAX GINSENG, RHUS TOX, HYDRASTIS CANADENSIS, UNCARIA TOMENTOSA, CARTILAGO SUIS, HORDEUM VULGARE, OXALICUM ACIDUM, ARNICA MONTANA, LATRODECTUS MACTANS, MAGNESIA PHOSPHORICA, MANGANUM METALLICUM, BORRELIA BURGDORFERI, BABESIA MICROTI | Nutritional Specialties, Inc. | 34dc93af-0c39-4e06-a8d6-9e1ccc77aa23 | 2023-03-17 | Warnings | 660YQ98I10 |
| NOVOLOG | INSULIN ASPART | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | fcd4f458-ce27-417e-9bb6-de1cc49d44b9 | 2023-02-27 | Warnings, Adverse reactions | 660YQ98I10 |
| K-Phos No. 2 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | Beach Products, Inc. | 9f446400-c403-4971-879e-1341f7f7d9da | 2023-02-23 | Adverse reactions | 4J9FJ0HL51 |
| K Phos Original | POTASSIUM PHOSPHATE, MONOBASIC | Beach Products, Inc. | 04557ab3-6d21-49b4-b849-744c75b8a630 | 2023-02-23 | Adverse reactions | 4J9FJ0HL51 |
| K Phos Neutral | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Beach Products, Inc. | 83376725-ee0f-40ad-bd90-31a61b9445cf | 2023-02-23 | Adverse reactions | 22ADO53M6F 4J9FJ0HL51 |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 1ef4a040-7bee-11e6-8371-424c58303031 | 2023-02-20 | 451W47IQ8X | |
| Natrum phosphoricum | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | Boiron | 12e87e30-7c60-11e6-869d-424c58303031 | 2023-02-20 | 70WT22SF4B | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645e304-a71b-5cba-e053-2a91aa0a2d88 | 2023-02-20 | 451W47IQ8X | |
| EyeClear Pro | CALC CARB, CALC FLUOR, CAUSTICUM, CINERARIA, EUPHRASIA, NAPHTHALINUM, NAT MUR, PHOS, QUASSIA, SILICEA | Silver Star Brands | f4d4943b-cb78-aa71-e053-2a95a90ac638 | 2023-02-16 | Warnings | 451W47IQ8X |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 87cc7349-5a07-4a39-be97-4e1013814f30 | 2023-02-06 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 9f8d2886-9ecd-4cbf-a84a-2d221cb3497c | 2023-01-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86463b98-58f5-7f65-e053-2a91aa0ad3a2 | 2023-01-23 | 451W47IQ8X | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608d5a3-93e6-e8e2-e053-2a91aa0aaedc | 2023-01-23 | 660YQ98I10 | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645f130-6a19-ae73-e053-2991aa0ab05b | 2023-01-23 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8645eb60-65d1-9d6c-e053-2991aa0a94ef | 2023-01-23 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8644ffef-f0e6-5c06-e053-2a91aa0ae83d | 2023-01-23 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.